Bleomycin sulfate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for bleomycin sulfate and what is the scope of patent protection?
Bleomycin sulfate
is the generic ingredient in two branded drugs marketed by Bristol Myers Squibb, Cipla, Fresenius Kabi Usa, Hikma, Hospira, Meitheal, Pharmachemie Bv, Teva Parenteral, and Teva Pharms Usa, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for bleomycin sulfate. Six suppliers are listed for this compound.
Summary for bleomycin sulfate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 9 |
NDAs: | 9 |
Drug Master File Entries: | 4 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 79 |
Patent Applications: | 7,511 |
What excipients (inactive ingredients) are in bleomycin sulfate? | bleomycin sulfate excipients list |
DailyMed Link: | bleomycin sulfate at DailyMed |
Recent Clinical Trials for bleomycin sulfate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Jinnah Postgraduate Medical Centre | Phase 2 |
University of California, Los Angeles | Phase 1 |
The Emmes Company, LLC | Phase 1 |
Pharmacology for bleomycin sulfate
Drug Class | Cytoprotective Agent |
Medical Subject Heading (MeSH) Categories for bleomycin sulfate
Anatomical Therapeutic Chemical (ATC) Classes for bleomycin sulfate
US Patents and Regulatory Information for bleomycin sulfate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Parenteral | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 064084-001 | Jun 1, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharmachemie Bv | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 065201-001 | Dec 13, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Pharms Usa | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 065033-001 | Jun 27, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Pharms Usa | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 065033-002 | Jun 27, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.